Ticker Details
TransCode Therapeutics, Inc.
IPO Date:	July 9, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$9.12M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 6.76%
Avg Daily Range (30 D):	$0.40 | 6.45%
Avg Daily Range (90 D):	$0.27 | 3.80%

Institutional Daily Volume
Avg Daily Volume:	.05M
Avg Daily Volume (30 D):	.1M
Avg Daily Volume (90 D):	.04M

Trade Size
Avg Trade Size (Sh.):	9
Avg Trade Size (Sh.) (30 D):	72
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	16
Avg Institutional Trade:	$.76M
Avg Institutional Trade (30 D):	$.57M
Avg Institutional Trade (90 D):	$.57M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$.65M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Feb 18, 2026 @ 3:49 PM Checkpoint Inhibitors Competitive Landscape Report... Source: Researchandmarkets.Com

Dec 22, 2025 @ 1:01 PM TransCode Therapeutics Expands Leadership with App... Source: Prnewswire

Oct 8, 2025 @ 2:48 PM TransCode Makes Bold Bet On Melanoma Vaccine With ... Source: Triveni Kothapalli

May 5, 2025 @ 10:27 AM US Stocks Likely To Open Lower After S&P 500's 9-D... Source: Rishabh Mishra

Jul 23, 2024 @ 5:26 PM Why Transcode Therapeutics (RNAZ) Stock Is Down 60... Source: Henry Khederian

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-21.28	$-18.1	$-52.59
Diluted EPS	$-21.28	$-18.1	$-52.59
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-17.79M	$-13.44M	$-34.66M
Operating Income / Loss	$-17.76M	$-16.03M	$-27.98M
Cost of Revenue
Net Cash Flow	$-4.98M	$12M	$12M
PE Ratio

Splits
May 15, 2025	1:28
Dec 04, 2024	1:33
Jan 16, 2024	1:40
May 23, 2023	1:20